A

ARTV

ARTV

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
40%Neutral
Buy/Sell Ratio98% buys
BearishBullish
ARTV Live QuoteReal-time
$3.78
$2.42(-39.03%)1M
Day Range$3.77 – $3.93
Open$3.82
Previous Close$3.83
Volume1.77M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$189.33M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.85
Price to Book0.6
Dividend Yield0.65%
Beta (Volatility)2.68
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $3.78 (7%)
Low: $2.96High: $14.53
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$20.75-86.2% upside

Insider Buys

11

$109.18M

Insider Sales

21

$2.74M

Total Volume

$111.92M

32 transactions

Net Activity

+$106.44M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
80CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Strong buying bias: purchases represent 98% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
R
1

Ra Capital Management, L.P.

Dir, 10%

10 buys0 sells

$92.68M total

G
2

Gc Corp.

10%

1 buys0 sells

$16.50M total

A
3

Aslan Fred

CEO

0 buys9 sells

$2.04M total

H
4

Horan Christopher

Chief Tech Operations Officer

0 buys3 sells

$249K total

B
5

Bush Jennifer

COO, CLO, Compliance Officer

0 buys3 sells

$230K total

Trading History
ARTV insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 6, 2026

1 months ago

Aslan Fred

CEO

CEO
Sell23.5K$7.20$169K

Oct 5, 2026

1 months ago

Horan Christopher

Chief Tech Operations Officer

C-Level
Sell10.3K$6.84$71K

Oct 5, 2026

1 months ago

Bush Jennifer

COO, CLO, Compliance Officer

COO
Sell8.4K$6.84$57K

Oct 5, 2026

1 months ago

Banerjee Subhashis

Chief Medical Officer

C-Level
Sell1.1K$6.84$8K

Oct 5, 2026

1 months ago

Aslan Fred

CEO

CEO
Sell61.7K$6.84$422K

Sep 8, 2026

2 months ago

Aslan Fred

CEO

CEO
Sell23.4K$10.92$256K

Sep 3, 2026

2 months ago

Horan Christopher

Chief Tech Operations Officer

C-Level
Sell10.4K$11.16$116K

Sep 3, 2026

2 months ago

Bush Jennifer

COO, CLO, Compliance Officer

COO
Sell8.4K$11.16$94K

Sep 3, 2026

2 months ago

Banerjee Subhashis

Chief Medical Officer

C-Level
Sell1.1K$11.16$12K

Sep 3, 2026

2 months ago

Aslan Fred

CEO

CEO
Sell61.9K$11.16$690K

Aug 27, 2026

2 months ago

Banerjee Subhashis

Chief Medical Officer

C-Level
Sell8.2K$12.01$99K

Aug 18, 2026

3 months ago

Banerjee Subhashis

Chief Medical Officer

C-Level
Sell429$12.00$5K

Jul 29, 2026

3 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy45.8K$9.96$456K

Jul 24, 2026

3 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy41.3K$9.99$413K

Jul 21, 2026

4 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy264.6K$9.76$2.58M

Jul 13, 2026

4 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy6.5K$8.94$58K

Jul 16, 2026

4 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy160.4K$8.93$1.43M

Jul 10, 2026

4 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy21.7K$8.96$194K

Jun 25, 2026

4 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy32.9K$8.89$292K

Jun 12, 2026

5 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy531.3K$8.66$4.60M

Jun 9, 2026

5 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy1.03M$7.44$7.65M

May 11, 2026

6 months ago

Gc Corp.

10%

10% Owner
Buy1.43M$11.52$16.50M

May 19, 2026

6 months ago

Raymon Heather

SVP, Research, Development

SVP
Sell3.1K$9.01$28K

May 19, 2026

6 months ago

Horan Christopher

Chief Tech Operations Officer

C-Level
Sell7.0K$9.01$63K

May 19, 2026

6 months ago

Bush Jennifer

COO, CLO, Compliance Officer

COO
Sell8.8K$9.01$79K

May 19, 2026

6 months ago

Banerjee Subhashis

Chief Medical Officer

C-Level
Sell7.0K$9.01$63K

May 19, 2026

6 months ago

Aslan Fred

CEO

CEO
Sell27.1K$9.01$244K

May 11, 2026

6 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy6.51M$11.52$75.00M

Dec 15, 2025

11 months ago

Aslan Fred

Pres, CEO

CEO
Sell3.2K$6.00$19K

Nov 17, 2025

12 months ago

Aslan Fred

Pres, CEO

CEO
Sell6.4K$3.38$22K

Oct 17, 2025

13 months ago

Aslan Fred

Pres, CEO

CEO
Sell25.5K$6.00$153K

Aug 15, 2025

15 months ago

Aslan Fred

Pres, CEO

CEO
Sell25.5K$2.73$70K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ARTV Buy Conviction98%
Industry Rank#0 of 569
Volume Contribution0.7%
Total Industry Activity$16.52B

ARTV has an insider buy conviction of 98%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ARTV

Over the last 90 days, corporate insiders at ARTV (ARTV) engaged in a total of 32 transactions reported via SEC Form 4 filings. Among these, 11 were open-market purchases and 21 were sales. The total volume of insider trading reached $111.92M.

The net insider activity for ARTV shows a net buying bias of $106.44M. This activity represents a 98% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Ra Capital Management, L.P. (Dir, 10%), who traded 6.51M shares valued at $75.00M on May 11, 2026.

Live Market News & Developments
Aggregated real-time headlines for ARTV (ARTV)
6 updates

Artiva Biotherapeutics (ARTV) Stock Forum and Discussion

Moomoo6d ago

Artiva Scraps Development Of Lead Drug Candidate After Patient Deaths — ARTV Stock Heads For Worst Session In Over 18 Months

Yahoo Finance24d ago

ARTV Stock Price and Chart — NASDAQ:ARTV

TradingView163d ago

ARTV - Artiva Biotherapeutics Inc Stock Price and Quote

Finviz176d ago

Should I buy Artiva Biotherapeutics, Inc. (ARTV)

Zacks Investment Research135d ago

Artiva slumps after discontinuing lead asset

Seeking Alpha24d ago

FAQs About ARTV Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ARTV.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ARTV is currently 80/100, which reflects a strong accumulation bias. This calculation accounts for a total of 11 purchases and 21 sales by company executives over the last 90 days.

The CEO Conviction Index for ARTV is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.